The lung Cancer Screening Market size was valued at USD 2.36 Billion in 2022 and the total Lung Cancer Screening revenue is expected to grow at a CAGR of 8.32% from 2023 to 2029, reaching nearly USD 4.13 Billion.
lung Cancer Screening Market Overview
The report lung Cancer Screening Market by Maximize Market Research provides detailed overview of the lung Cancer Screening Market. The lung Cancer Screening Market Report covers all the major dynamics including strategies, pricing analysis, micro and macro Market trends and scenarios, Industry rivalry, and short-term Market circumstances. This helps to understand the Market structure in detail. The report also provides detailed analysis of the segment wise trend
Do you have any questions? Ask our experts:https://www.maximizemarketresearch.com/inquiry-before-buying/166924
lung Cancer Screening Market Report Scope and Research Methodology
The report provides the lung Cancer Screening Market's present size, growth rates, and company profiles of the top players and producers. The report offers the Market share and rival sector and an analysis of the key vendors and leading regions. The report gives a detailed analysis of the Market and includes meaningful insights, facts, historical data, and statistically supported and industry-validated Market statistics on lung Cancer Screening. The bottom-up approach was used to estimate the Market size. The Market revenue is determined by the primary and secondary data collection sources.
Request for a Sample Report to get a more detailed analysis of the other segments:https://www.maximizemarketresearch.com/request-sample/166924
A thorough analysis of the regional environment is included, along with information on the potential, important growth indicators, geographical challenges, and threats facing the Market. The segment-wise analysis is categorized into #, # and #. The following details are offered: a description of the company, its primary operations, total earnings and sales, revenue generated in the Market, the entry date into the Market, recent developments, and other details. The qualitative and quantitative approaches are analyzed in the report.
Market Segmentation
Based on cancer type, the Non-small Cell Lung Cancer (NSCLC) segment held the largest market share of 78% in the worldwide lung cancer screening market in 2022. At the end of the forecast period, this sector is anticipated to continue to dominate with the greatest market share of 85%. With 85% of cases of lung cancer being non-small cell lung cancer (NSCLC), it is the most prevalent type of cancer. Large cell carcinoma, adenocarcinoma, squamous cell carcinoma, and other less frequent kinds of NSCLC are examples of NSCLC subtypes. Over the forecast period, segment growth is anticipated to be fueled by rising NSCLC incidence globally and increased screening awareness in developed and emerging nations.
The Low Dose Spiral CT Scan sector had the biggest market share in 2022, accounting for almost 74% of all diagnoses types. At the conclusion of the forecast period, the category is anticipated to lead the lung cancer screening market. During the projected period, segment growth is anticipated to be driven by the favourable reimbursement laws for cancer screening and the growing acceptance of low-dose spiral CT scan. Additionally, throughout the projected period, market growth is anticipated to be influenced by growing awareness of the mortality benefits of low-dose spiral CT scan screening.
Market Key Players
1. GE Healthcare (United States)
2. PenRad Technologies, Inc. (United States)
3. NanoString, Myriad Genetics Inc. (United States)
4. OncoCyte (United States)
5. Biodesix (United States)
6. Broncus (United States)
7. Abbott (United States)
8. Illumina, Inc., (United States)
9. Thermo Fischer Scientific (United States)
10. Medtronic (United States)
11. Nuance Communications, Inc. (United States)
12. Riverain Tech (United States)
13. 20/20 Gene Systems (United States)
14. Danaher Corporation (United States)
15. NeoGenomics (United States)
16. Eon Health (United States)
17. Siemens Healthineers AG (Germany)
18. Agilent Technologies, Inc., AstraZeneca (United Kingdom)
19. Insight Genetics (United Kingdom)
20. Inivata (United Kingdom)
21. Oncimmune (United Kingdom)
22. Koninklijke Philips N.V. (The Netherlands)
23. QIAGEN (The Netherlands)
24. Quest Diagnostics Incorporated (The Netherlands)
25. F. Hoffmann-La Roche Ltd. (Switzerland)
26. Janssen Pharmaceuticals, Inc. (Belgium)
27. Sanofi, (France)
28. Canon Medical Systems Corporation (Japan)
29. FUJIFILM Holdings Corporation (Japan)
30. VisionGate (India)
31. Integrated Diagnostics (India)
32. Volpara Solutions Limited. (New Zealand)
Market Regional Insights
The lung Cancer Screening Market is broadly segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The report involves a thorough analysis of all the factors, Market size, growth rate, and import and export in regions.
Do You Have Any Questions About This Report? Please Contact Us On link:https://www.maximizemarketresearch.com/inquiry-before-buying/166924
Key questions answered in the Market are:
- What is lung Cancer Screening?
- What was the lung Cancer Screening Market size in 2023?
- What is the growth rate of the lung Cancer Screening Market?
- Which are the factors expected to drive the lung Cancer Screening Market growth?
- What are the upcoming industry applications and trends for the Market?
- What are the recent industry trends that can be implemented to generate additional revenue streams for the Market?
- What segments are covered in the Market?
- Who are the leading companies and what are their portfolios in Market?
- What segments are covered in the Market?
- What is the demand pattern of the Market?
- What major challenges could the Market face in the future?
- Who are the key players in the Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2022)
- Past Pricing and price curve by region (2018 to 2022)
- Market Size, Share, Size Forecast by different segment | 2023−2029
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of Business by Region
- Lucrative business opportunities with SWOT analysis
- Recommendations
About Maximize Market Research:
Maximize Market Research is a multifaceted Market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide Market-verified industry estimations, technical trend analysis, crucial Market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, IndiaC
+91 96071 95908, +91 9607365656
